When Novartis said in June that it would spin off its long-struggling eye-care unit, Alcon, CEO Vas Narasimhan declined to estimate what the valuation on such a transaction might be. But his ...

Staar Surgical will remain independent after a bitter shareholder battle that has raged for the past several months has now ...

Alcon and STAAR Surgical terminated their definitive merger agreement. According to a press release from STAAR, preliminary ...

Staar Surgical announced that preliminary estimates suggest that it failed to receive stockholder approval for its planned ...

STAAR Surgical said on Tuesday it plans to terminate its merger agreement with Swiss eyecare giant Alcon after failing to ...

STAAR Surgical has announced that it will terminate the proposed acquisition by Alcon based on preliminary estimates by STAAR ...

Alcon has bought up Belkin Vision and its laser device for treating glaucoma. The deal includes an upfront transfer of $81 million, including about $65 million in cash—plus the opportunity for up to ...

STAAR Surgical is terminating its agreement to merge with Swiss eyecare specialist Alcon in a $1.6bn deal, ending a ...

GENEVA--(BUSINESS WIRE)--Regulatory News: Alcon Inc. (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced the approval of all proposed binding ...

I reiterate a 'Strong Buy' rating for Alcon with a one-year price target of $115 per share, driven by new product pipelines and FDA clearances. Alcon's Unity VCS/CS systems received FDA clearance, set ...